Gold prices steady ahead of Fed decision; weekly weakness noted
BOCA RATON, FL—Marlan D. Walker, the Chief Executive Officer of TherapeuticsMD, Inc. (NASDAQ:TXMD), recently purchased 490 shares of the company’s common stock. This transaction, valued at approximately $489, took place on April 14, 2025, at a price of $0.9985 per share. The stock has since risen to $1.03, showing a strong weekly gain of 17%. According to InvestingPro analysis, the company’s shares are currently trading near their Fair Value.
Following this purchase, Walker now owns a total of 73,639 shares directly. The acquisition reflects his continued investment in the pharmaceutical company, which is headquartered in Boca Raton, Florida. The company, with a market capitalization of $11.92 million, maintains a healthy financial position with a current ratio of 2.37. InvestingPro subscribers can access 8 additional key insights about TXMD’s financial health and growth prospects ahead of its earnings report on May 8.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.